Cargando…

Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review

Escherichia coli is a versatile commensal and pathogenic member of the human microflora. As the primary causative pathogen in urosepsis, E. coli places an immense burden on healthcare systems worldwide. To further exacerbate the issue, multi drug resistance (MDR) has spread rapidly through E. coli p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Mikaela M., Roberts, Jason A., Rogers, Benjamin A., Harris, Patrick N. A., Sime, Fekade B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774639/ https://www.ncbi.nlm.nih.gov/pubmed/36551478 http://dx.doi.org/10.3390/antibiotics11121821

Ejemplares similares

Native valve Escherichia coli endocarditis following urosepsis
por: Rangarajan, D., et al.
Publicado: (2013)

A Novel Method of Serum Resistance by Escherichia coli That Causes Urosepsis
por: Coggon, Carrie F., et al.
Publicado: (2018)

Genome Sequence of Escherichia coli KI683, Isolated from a Urosepsis Patient
por: Stefani, Nathalie, et al.
Publicado: (2020)

Escherichia hermannii as the sole pathogen in urosepsis: case report
por: Haasdijk, R.A., et al.
Publicado: (2017)

A novel model of urosepsis in rats developed by injection of Escherichia coli into the renal pelvis
por: Cao, Yuanfei, et al.
Publicado: (2023)

Emergency Department Urosepsis and Abdominal Imaging
por: Siddiqui, Mansoor, et al.
Publicado: (2021)

Cytotoxic Escherichia coli strains encoding colibactin isolated from immunocompromised mice with urosepsis and meningitis
por: Bakthavatchalu, Vasudevan, et al.
Publicado: (2018)

Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model
por: Islam, Kamrul, et al.
Publicado: (2022)

Urosepsis and the urologist!
por: Ryan, James, et al.
Publicado: (2021)

Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins
por: Tocut, Milena, et al.
Publicado: (2022)

Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis
por: Cuénod, Aline, et al.
Publicado: (2023)

Procalcitonin as an indicator of urosepsis
por: Sugimoto, Koichi, et al.
Publicado: (2013)

Multidrug-Resistant Escherichia coli Bacteremia
por: Alhashash, Fahad, et al.
Publicado: (2013)

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
por: Wong, Gloria, et al.
Publicado: (2014)

Approach to a Patient with Urosepsis
por: Kalra, Om Prakash, et al.
Publicado: (2009)

The Urosepsis—A Literature Review
por: Guliciuc, Mădălin, et al.
Publicado: (2021)

Obstructive hydronephrosis with secondary urosepsis
por: Hsu, Shao‐Lun, et al.
Publicado: (2022)

Multidrug-Resistant Escherichia coli in Bovine Animals, Europe
por: Brennan, Evan, et al.
Publicado: (2016)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

A case of urosepsis with atypical presentation
por: Ólafsdóttir, Björk, et al.
Publicado: (2010)

Prevention and management of urosepsis triggered by ureteroscopy
por: Scotland, Kymora B, et al.
Publicado: (2018)

Differential protein expression in patients with urosepsis
por: Yang, Xu-Kai, et al.
Publicado: (2018)

Takotsubo Cardiomyopathy in a Nonagenarian With Urosepsis
por: Sendil, Selin, et al.
Publicado: (2020)

Prepubic inflammatory liposarcoma presenting as urosepsis
por: Khattar, Manish, et al.
Publicado: (2023)

Diagnostic and therapeutic value of biomarkers in urosepsis
por: Wu, Yuyun, et al.
Publicado: (2023)

The Role of Biomarkers and Scores in Describing Urosepsis
por: Guliciuc, Mădălin, et al.
Publicado: (2023)

Dynamics of Urinary Extracellular DNA in Urosepsis
por: Mihaľová, Michaela, et al.
Publicado: (2023)

Development of multidrug-resistant Escherichia coli in some Egyptian veterinary farms
por: Samy, A. A., et al.
Publicado: (2022)

Seagulls and Beaches as Reservoirs for Multidrug-Resistant Escherichia coli
por: Simões, Roméo Rocha, et al.
Publicado: (2010)

Phage Engineering for Targeted Multidrug-Resistant Escherichia coli
por: Song, Jiaoyang, et al.
Publicado: (2023)

Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients
por: Zafer, Mai M., et al.
Publicado: (2019)

The Emergence of Colistin- and Imipenem-Associated Multidrug Resistance in Escherichia Coli Isolates from Retail Meat
por: Iweriebor, Benson Chuks, et al.
Publicado: (2022)

Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone
por: Schembri, Mark A., et al.
Publicado: (2015)

ESBL E. coli Urosepsis Resulting in Endogenous Panophthalmitis Requiring Evisceration of the Eye in a Diabetic Patient
por: Arunachala Murthy, Tejaswini, et al.
Publicado: (2015)

Transplant uretero-inguinal hernia resulting in urosepsis
por: Areda, Moustafa Abou, et al.
Publicado: (2018)

Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis
por: Jiang, Ying, et al.
Publicado: (2019)

Catheter-associated Hafnia alvei-induced Urosepsis
por: Yarlagadda, Keerthi, et al.
Publicado: (2019)

Prognostic values of procalcitonin and platelet in the patient with urosepsis
por: Jiang, Ling, et al.
Publicado: (2021)

Thromboelastography Parameters in Urosepsis: A Retrospective Study
por: Qiao, Yun, et al.
Publicado: (2022)

Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant
por: Liu, Qiuying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kjvll3n4iq70dc23meuhcnga3m